RESUMO
OBJECTIVE: The relative refractory period (RRP) of motor axons is an important parameter in nerve excitability tests of the recovery cycle (RC). Abnormalities may have a site in the axonal membrane, the neuromuscular junction, or in a dysfunction of the muscle. We aimed in this study to determine the site of abnormality, using a modified protocol of the conventional RC test, whereby an additional supramaximal stimulus is added at the same interstimulus interval as in RC recordings (RCSM). METHODS: Twenty-four healthy subjects aged 37.8⯱â¯2.4â¯years (mean⯱â¯SE) were examined with median nerve excitability testing using RC and RCSM protocols at normal temperature (34.1⯱â¯0.2⯰C). The recordings were repeated in 12 subjects after selective cooling of the thenar muscle (25.2⯱â¯0.7⯰C) and in 12 subjects after cooling the nerve trunk at the wrist (24.9⯱â¯0.3⯰C). RESULTS: After cooling the nerve, RRP measured with RC and RCSM were prolonged similarly (medians by 1.8â¯ms, and 2.1â¯ms respectively). In contrast, cooling the muscle prolonged RRP measured with RC (by 1.3â¯ms), but did not significantly prolong RRP measured with RCSM. RRPs measured by RC and RCSM were significantly different when cooling was at the muscle (Pâ¯=â¯5.10-4), but not when cooling was at the nerve (Pâ¯=â¯0.57). CONCLUSIONS: A difference between RC and RCSM indicates abnormal excitability distal to the axonal membrane under the stimulating electrode. SIGNIFICANCE: Combining RCSM with the conventional RC protocol should help to localize the site of abnormal neuromuscular refractoriness.
RESUMO
INTRODUCTION: Cold allodynia is often seen in the acute phase of oxaliplatin treatment, but the underlying pathophysiology remains unclear. METHODS: Patients scheduled for adjuvant oxaliplatin for colorectal cancer were examined with quantitative sensory testing and nerve excitability tests at baseline and after the second or third oxaliplatin cycle at different skin temperatures. RESULTS: Seven patients were eligible for examination. All patients felt evoked pain and tingling when touching something cold after oxaliplatin infusion. Oxaliplatin decreased motor nerve superexcitability (P < .001), increased relative refractory period (P = .011), and caused neuromyotonia-like after-activity. Cooling exacerbated these changes and prolonged the accommodation half-time. DISCUSSION: The findings suggest that a combined effect of oxaliplatin and cooling facilitates nerve excitability changes and neuromyotonia-like after-activity in peripheral nerve axons. A possible mechanism is the slowing in gating of voltage-dependent fast sodium and slow potassium channels, which results in symptoms of cold allodynia.
Assuntos
Antineoplásicos/efeitos adversos , Axônios/fisiologia , Temperatura Baixa/efeitos adversos , Hiperalgesia/induzido quimicamente , Neurônios Motores/fisiologia , Oxaliplatina/efeitos adversos , Idoso , Axônios/efeitos dos fármacos , Neoplasias do Colo/tratamento farmacológico , Feminino , Seguimentos , Humanos , Hiperalgesia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Neurônios Motores/efeitos dos fármacos , Estudos Prospectivos , Resultado do TratamentoRESUMO
The term 'Neurofibromatosis' (NF) comprises a group of rare diseases with related clinical presentations but distinct genetic conditions. All currently known types - NF1, NF2 and Schwannomatosis - predispose afflicted individuals to the development of glial cell-derived (gliogenic) tumors. Furthermore, the occurrence of neuropathic symptoms, which add to the overall neurologic disability of patients, has been described in all disease entities. We show that neuropathic symptoms are a common and clinically important, yet infrequently studied feature in the NF spectrum. However, the clinical relevance and respective underlying pathogenesis, varies greatly among the different NF types. In this review, we summarize and interpret the latest basic research findings, as well as clinical observations, in respect of Neurofibromatosis-associated neuropathies.
Assuntos
Doenças do Sistema Nervoso/etiologia , Neurofibromatoses/complicações , Adulto , Idade de Início , Animais , Axônios/patologia , Criança , Doenças Desmielinizantes/etiologia , Doenças Desmielinizantes/patologia , Doenças Desmielinizantes/fisiopatologia , Modelos Animais de Doenças , Eletrofisiologia , Humanos , Camundongos , Terapia de Alvo Molecular , Compressão Nervosa , Neuralgia/etiologia , Neuralgia/fisiopatologia , Neuralgia/terapia , Neurilemoma/complicações , Neurilemoma/fisiopatologia , Neurofibromatoses/fisiopatologia , Neuroimagem , Manejo da Dor , Psicoterapia , Nervo Isquiático/patologia , Transtornos de Sensação/etiologia , Transtornos de Sensação/fisiopatologia , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/fisiopatologiaRESUMO
OBJECTIVE: Neurotoxicity is the most frequent dose-limiting side effect of the anti-cancer agent oxaliplatin, but the mechanisms are not well understood. This study used nerve excitability testing to investigate the pathophysiology of the acute neurotoxicity. METHODS: Questionnaires, quantitative sensory tests, nerve conduction studies and nerve excitability testing were undertaken in 12 patients with high-risk colorectal cancer treated with adjuvant oxaliplatin and in 16 sex- and age-matched healthy controls. Examinations were performed twice for patients: once within 3â¯days after oxaliplatin treatment (post-infusion examination) and once shortly before the following treatment (recovery examination). RESULTS: The most frequent post-infusion symptoms were tingling paresthesias and cold allodynia. The most prominent nerve excitability change was decreased superexcitability of motor axons which correlated with the average intensity of abnormal sensations (Spearman Rhoâ¯=â¯0.80, pâ¯<â¯.01). The motor nerve excitability changes were well modeled by a slowing of sodium channel inactivation, and were proportional to dose/m2 with a half-life of about 10d. CONCLUSIONS: Oxaliplatin induces reversible slowing of sodium channel inactivation in motor axons, and these changes are closely related to the reversible cold allodynia. However, further studies are required due to small sample size in this study. SIGNIFICANCE: Nerve excitability data provide an index of sodium channel dysfunction: an objective biomarker of acute oxaliplatin neurotoxicity.
Assuntos
Antineoplásicos/efeitos adversos , Axônios/efeitos dos fármacos , Hiperalgesia/induzido quimicamente , Síndromes Neurotóxicas/diagnóstico , Oxaliplatina/efeitos adversos , Parestesia/induzido quimicamente , Canais de Sódio/metabolismo , Adulto , Idoso , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Axônios/metabolismo , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/fisiopatologia , Feminino , Humanos , Hiperalgesia/metabolismo , Hiperalgesia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/metabolismo , Condução Nervosa/efeitos dos fármacos , Síndromes Neurotóxicas/metabolismo , Síndromes Neurotóxicas/fisiopatologia , Oxaliplatina/farmacologia , Oxaliplatina/uso terapêutico , Parestesia/metabolismo , Parestesia/fisiopatologia , Inquéritos e QuestionáriosRESUMO
INTRODUCTION: The neuropathy in patients with neurofibromatosis type 2 (NF2) is difficult to quantify and follow up. In this study we compared 3 methods that may help assess motor axon pathology in NF2 patients. METHODS: Nerve conduction studies in median nerves were supplemented by deriving motor unit number estimates (MUNEs) from compound muscle action potential (CMAP) scans and by high-resolution ultrasound (US) peripheral nerve imaging. RESULTS: CMAP amplitudes and nerve conduction velocity were normal in the vast majority of affected individuals, but CMAP scan MUNE revealed denervation and reinnervation in many peripheral nerves. In addition, nerve US imaging enabled monitoring of the size and number of schwannoma-like fascicular enlargements in median nerve trunks. CONCLUSION: In contrast to conventional nerve conduction studies, CMAP scan MUNE in combination with US nerve imaging can quantify the NF2-associated neuropathy and may help to monitor disease progression and drug treatments. Muscle Nerve 55: 350-358, 2017.
Assuntos
Potenciais de Ação/fisiologia , Músculo Esquelético/diagnóstico por imagem , Músculo Esquelético/fisiopatologia , Neurofibromatose 2/diagnóstico por imagem , Neurofibromatose 2/patologia , Ultrassonografia , Adolescente , Adulto , Idoso , Criança , Eletrofisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neurônios Motores/fisiologia , Condução Nervosa/fisiologia , Neurofibromatose 2/complicações , Nervos Periféricos/diagnóstico por imagem , Adulto JovemRESUMO
Infusion of the chemotherapeutic agent oxaliplatin leads to an acute and a chronic form of peripheral neuropathy. Acute oxaliplatin neuropathy is characterized by sensory paresthesias and muscle cramps that are notably exacerbated by cooling. Painful dysesthesias are rarely reported for acute oxaliplatin neuropathy, whereas a common symptom of chronic oxaliplatin neuropathy is pain. Here we examine the role of the sodium channel isoform Na(V)1.6 in mediating the symptoms of acute oxaliplatin neuropathy. Compound and single-action potential recordings from human and mouse peripheral axons showed that cooling in the presence of oxaliplatin (30-100 µM; 90 min) induced bursts of action potentials in myelinated A, but not unmyelinated C-fibers. Whole-cell patch-clamp recordings from dissociated dorsal root ganglion (DRG) neurons revealed enhanced tetrodotoxin-sensitive resurgent and persistent current amplitudes in large, but not small, diameter DRG neurons when cooled (22 °C) in the presence of oxaliplatin. In DRG neurons and peripheral myelinated axons from Scn8a(med/med) mice, which lack functional Na(V)1.6, no effect of oxaliplatin and cooling was observed. Oxaliplatin significantly slows the rate of fast inactivation at negative potentials in heterologously expressed mNa(V)1.6r in ND7 cells, an effect consistent with prolonged Na(V) open times and increased resurgent and persistent current in native DRG neurons. This finding suggests that Na(V)1.6 plays a central role in mediating acute cooling-exacerbated symptoms following oxaliplatin, and that enhanced resurgent and persistent sodium currents may provide a general mechanistic basis for cold-aggravated symptoms of neuropathy.
Assuntos
Antineoplásicos/farmacologia , Proteínas do Tecido Nervoso/efeitos dos fármacos , Compostos Organoplatínicos/farmacologia , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Canais de Sódio/efeitos dos fármacos , Animais , Axônios , Gânglios Espinais/citologia , Gânglios Espinais/fisiologia , Humanos , Camundongos , Canal de Sódio Disparado por Voltagem NAV1.6 , Proteínas do Tecido Nervoso/fisiologia , Neurônios/fisiologia , Oxaliplatina , Canais de Sódio/fisiologiaRESUMO
Changes in the excitability of peripheral myelinated axons in response to long-lasting subthreshold depolarizing or hyperpolarizing currents (threshold electrotonus) are used as a complementary electrophysiological parameter in the study of peripheral nerve diseases in people. However, the contribution made by various axonal ion channels to specific components of threshold electrotonus remains incompletely understood. In this study, we have recorded threshold electrotonus responses from isolated nerve segments of sural nerve from control and Scn8amed mice, which lack functional Nav1.6 voltage-gated sodium channel. In med mice, the increase in axonal excitability produced by application of subthreshold depolarizing currents for 100-200ms was not sustained. In contrast, there was no difference in threshold electrotonus responses to subthreshold hyperpolarizing current application between Scn8amed and control mice. These data reveal the specific functional role of an identified subtype of voltage-gated sodium channel (Nav1.6) in mediating the depolarizing threshold electrotonus response of peripheral myelinated nerve fibers.
Assuntos
Potenciais de Ação/genética , Axônios/fisiologia , Fibras Nervosas Mielinizadas/fisiologia , Proteínas do Tecido Nervoso/genética , Condução Nervosa/genética , Nervos Periféricos/fisiologia , Canais de Sódio/genética , Animais , Ativação do Canal Iônico/genética , Camundongos , Camundongos Knockout , Canal de Sódio Disparado por Voltagem NAV1.6 , Técnicas de Cultura de Órgãos , Regulação para Cima/genéticaRESUMO
Oxaliplatin is used in the chemotherapeutic treatment of malignant tumours. A common side effect of oxaliplatin is an acute peripheral neuropathy characterized by axonal hyperexcitability, which can be painful and is aggravated by exposure to cold. Electrophysiological studies on isolated segments of peripheral rodent nerve have been able to replicate oxaliplatin's effect on axonal hyperexcitability in vitro. In the present study we have used this in vitro model to examine whether flupirtine, a clinically available analgesic, which activates slow axonal potassium (Kv7) channels, can suppress axonal hyperexcitability resulting from exposure of peripheral nerve to oxaliplatin. In the presence of oxaliplatin (30µM), the A-fibre compound action potential response of isolated rat nerve segments to a brief electrical stimulus (0.1ms) changed considerably with the emergence of after-activity that persisted for a period of tens of milliseconds after the electrical stimulus. Lowering the bath temperature by 4°C enhanced the magnitude and prolonged the time course of this axonal after-activity. Application of flupirtine (10µM) reduced both the magnitude and duration of oxaliplatin-induced axonal after-activity in myelinated axons. These findings were also confirmed in isolated human sural nerve segments. The data indicate that activation of slow potassium channels in the A-fibres of peripheral nerve may attenuate the acute neuropathy associated with oxaliplatin in humans.
Assuntos
Potenciais de Ação/fisiologia , Axônios/fisiologia , Condução Nervosa/fisiologia , Compostos Organoplatínicos/toxicidade , Doenças do Sistema Nervoso Periférico/fisiopatologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/fisiologia , Regulação para Cima/fisiologia , Potenciais de Ação/efeitos dos fármacos , Doença Aguda , Idoso , Animais , Axônios/efeitos dos fármacos , Axônios/patologia , Estimulação Elétrica/métodos , Feminino , Humanos , Masculino , Condução Nervosa/efeitos dos fármacos , Técnicas de Cultura de Órgãos , Oxaliplatina , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Ratos , Ratos Wistar , Nervo Sural/efeitos dos fármacos , Nervo Sural/patologia , Nervo Sural/fisiologia , Regulação para Cima/efeitos dos fármacosRESUMO
Flupirtine is an activator of Kv7 (KCNQ/M) potassium channels that has found clinical use as an analgesic with muscle relaxant properties. Kv7 potassium channels are expressed in axonal membranes and pharmacological activation of these channels may restore abnormal nerve excitability. We have examined the effect of flupirtine on the electrical excitability of myelinated axons in isolated segments of rat sural nerve. Axonal excitability was studied in vitro with the same parameters used by clinical neurophysiologists to assess peripheral nerve excitability in situ. Application of flupirtine in low micromolar concentrations resulted in an increase in threshold current, a reduction of refractoriness and an increase in post-spike superexcitability. These effects are consistent with an increase in Kv7 conductance and membrane hyperpolarization. Flupirtine also enhanced and prolonged the late, long-lasting period of axonal subexcitability that follows a short burst of action potentials. This effect was blocked by XE 991 (10 microM), an antagonist of Kv7 channels. In summary, flupirtine affects measures of excitability that are altered in the myelinated axons of patients with peripheral nerve disorders. This indicates that neuropathies with abnormal nerve excitability parameters corresponding to those affected by flupirtine may benefit from activation of axonal Kv7 potassium channels.
Assuntos
Aminopiridinas/farmacologia , Analgésicos/farmacologia , Axônios/efeitos dos fármacos , Canais de Potássio KCNQ/agonistas , Fibras Nervosas Mielinizadas/efeitos dos fármacos , Nervo Sural/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Aminopiridinas/administração & dosagem , Analgésicos/administração & dosagem , Animais , Antracenos/farmacologia , Axônios/fisiologia , Relação Dose-Resposta a Droga , Estimulação Elétrica , Técnicas In Vitro , Canais de Potássio KCNQ/antagonistas & inibidores , Canais de Potássio KCNQ/metabolismo , Masculino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Microeletrodos , Fibras Nervosas Mielinizadas/fisiologia , Bloqueadores dos Canais de Potássio/farmacologia , Ratos , Ratos Wistar , Nervo Sural/fisiologia , Fatores de TempoRESUMO
BACKGROUND: A proportion of small diameter primary sensory neurones innervating human skin are chemosensitive. They respond in a receptor dependent manner to chemical mediators of inflammation as well as naturally occurring algogens, thermogens and pruritogens. The neurotransmitter GABA is interesting in this respect because in animal models of neuropathic pain GABA pre-synaptically regulates nociceptive input to the spinal cord. However, the effect of GABA on human peripheral unmyelinated axons has not been established. METHODOLOGY/PRINCIPAL FINDINGS: Electrical stimulation was used to assess the effect of GABA on the electrical excitability of unmyelinated axons in isolated fascicles of human sural nerve. GABA (0.1-100 microM) increased electrical excitability in a subset (ca. 40%) of C-fibres in human sural nerve fascicles suggesting that axonal GABA sensitivity is selectively restricted to a sub-population of human unmyelinated axons. The effects of GABA were mediated by GABA(A) receptors, being mimicked by bath application of the GABA(A) agonist muscimol (0.1-30 microM) while the GABA(B) agonist baclofen (10-30 microM) was without effect. Increases in excitability produced by GABA (10-30 microM) were blocked by the GABA(A) antagonists gabazine (10-20 microM), bicuculline (10-20 microM) and picrotoxin (10-20 microM). CONCLUSIONS/SIGNIFICANCE: Functional GABA(A) receptors are present on a subset of unmyelinated primary afferents in humans and their activation depolarizes these axons, an effect likely due to an elevated intra-axonal chloride concentration. GABA(A) receptor modulation may therefore regulate segmental and peripheral components of nociception.
Assuntos
Axônios/fisiologia , Bainha de Mielina/metabolismo , Ácido gama-Aminobutírico/fisiologia , Estimulação Elétrica , Feminino , Humanos , Masculino , Receptores de GABA-A/fisiologiaRESUMO
BACKGROUND: Multiple voltage-dependent sodium channels (Na(v)) contribute to action potentials and excitability of primary nociceptive neurons. The aim of the current study was to characterize subtypes of Na(v) that contribute to action potential generation in peripheral unmyelinated human C-type nerve fibers. METHODS: Registration of C-fiber compound action potentials and determination of membrane threshold was performed by a computerized threshold tracking program. Nerve fibers were stimulated with a 1-ms current pulse either alone or after a small ramp current lasting 300 ms. RESULTS: Compound C-fiber action potentials elicited by supramaximal 1-ms current pulses were rather resistant to application of tetrodotoxin (30-90 nM). However, the same concentrations of tetrodotoxin strongly reduced the peak height and elevated membrane threshold of action potentials evoked at the end of a 300-ms current ramp. A similar effect was observed during application of lidocaine and mexiletine (50 microM each). CONCLUSIONS: These data indicate that more than one type of Na(v) contributes to the generation of action potentials in unmyelinated human C-type nerve fibers. The peak height of an action potential produced by a short electrical impulse is dependent on the activation of tetrodotoxin-resistant ion channels. In contrast, membrane threshold and action potential peak height at the end of a slow membrane depolarization are regulated by a subtype of Na(v) with high sensitivity to low concentrations of tetrodotoxin, lidocaine, and mexiletine. The electrophysiologic and pharmacologic characteristics may indicate the functional activity of the Na(v) 1.7 subtype of voltage-dependent sodium channels.
Assuntos
Potenciais de Ação/fisiologia , Fibras Nervosas Amielínicas/fisiologia , Bloqueadores dos Canais de Sódio/farmacologia , Canais de Sódio/fisiologia , Potenciais de Ação/efeitos dos fármacos , Anestésicos Locais/administração & dosagem , Anestésicos Locais/farmacologia , Antiarrítmicos/administração & dosagem , Antiarrítmicos/farmacologia , Estimulação Elétrica/métodos , Eletrofisiologia/métodos , Humanos , Técnicas In Vitro , Lidocaína/administração & dosagem , Lidocaína/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Mexiletina/administração & dosagem , Mexiletina/farmacologia , Fibras Nervosas Amielínicas/efeitos dos fármacos , Limiar Sensorial/efeitos dos fármacos , Limiar Sensorial/fisiologia , Bloqueadores dos Canais de Sódio/administração & dosagem , Canais de Sódio/efeitos dos fármacos , Tetrodotoxina/administração & dosagem , Tetrodotoxina/farmacologiaRESUMO
Vagal afferent neurons from the stomach may be activated not only by chemical stimuli in the mucosa but also by circulating factors. In the present study, we have used electrophysiological techniques to characterize functional activity of several receptors for chemical mediators on unmyelinated axons in isolated fascicles of human gastric vagus nerve. Application of agonists at the nicotinic acetylcholine receptor (nAChR), 5-HT(3) subtype of serotonin receptor, and the transient receptor potential vanilloid receptor-1 (TRPV1) resulted in a change in the height and/or threshold of the C-fiber compound action potential. These effects were blocked by specific antagonists of nAChR (mecamylamine), 5-HT(3) (Y-25130), and TRPV1 (capsazepine). We conclude that the chemosensitivity of unmyelinated vagal axons can be studied using isolated segments of human gastric vagus nerve. The presence of receptors indicates that circulating factors may modify vagal afferent neurons also by effects on the axonal membrane.
Assuntos
Células Quimiorreceptoras/fisiologia , Mucosa Gástrica/inervação , Mucosa Gástrica/fisiologia , Fibras Nervosas Amielínicas/fisiologia , Neurônios Aferentes/fisiologia , Nervo Vago/fisiologia , Fibras Aferentes Viscerais/fisiologia , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Idoso , Axônios/efeitos dos fármacos , Axônios/fisiologia , Capsaicina/farmacologia , Membrana Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Células Quimiorreceptoras/efeitos dos fármacos , Feminino , Humanos , Masculino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Pessoa de Meia-Idade , Fibras Nervosas Amielínicas/efeitos dos fármacos , Neurônios Aferentes/efeitos dos fármacos , Agonistas Nicotínicos/farmacologia , Gânglio Nodoso/efeitos dos fármacos , Gânglio Nodoso/fisiologia , Técnicas de Cultura de Órgãos , Receptores Nicotínicos/efeitos dos fármacos , Receptores Nicotínicos/fisiologia , Receptores 5-HT3 de Serotonina/efeitos dos fármacos , Receptores 5-HT3 de Serotonina/fisiologia , Agonistas do Receptor de Serotonina/farmacologia , Canais de Cátion TRPV/efeitos dos fármacos , Canais de Cátion TRPV/fisiologia , Nervo Vago/efeitos dos fármacos , Fibras Aferentes Viscerais/efeitos dos fármacosRESUMO
Recording of action potentials from single unmyelinated nerve fibers by microneurography is an important tool to investigate peripheral neural functions in human neuropathies. However, the interpretation of microneurography recordings can be difficult because axonal membrane potential is not revealed by this method. We tested the hypothesis that the recovery cycle of excitability after a single action potential is correlated with changes in the axonal membrane potential. To this end, we used the threshold tracking technique to study how different chemical mediators, with known effects on the membrane potential, influence the post-spike superexcitability of C-fiber compound action potentials in isolated rat sural and vagus nerves. We found that: (1) some chemical mediators (e.g., adenosine 5'-triphosphate) produce a reduction or loss of superexcitability together with increased axonal excitability, indicating membrane depolarization; (2) blockade of axonal hyperpolarization-activated (Ih) currents produces an enhancement of superexcitability together with a decreased excitability, indicating membrane hyperpolarization; and (3) application of calcium produces an increase in membrane threshold without an alteration in superexcitability, indicating a non-specific increase in surface charge and a change in the voltage-dependent activation of sodium channels. In addition, we demonstrated that membrane depolarization and hyperpolarization induce opposite post-spike latency shifts (changes in supernormality) in rat and human nerve segments. Thus, recordings of post-spike excitability and shifts in latency are sensitive techniques for detection of various types of neuromodulation, which are correlated with changes in membrane potential of unmyelinated peripheral axons and may help to understand observations obtained by microneurography in peripheral human neuropathies.
Assuntos
Potenciais da Membrana/fisiologia , Fibras Nervosas Amielínicas/fisiologia , Acetilcolina/farmacologia , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/farmacologia , Marcadores de Afinidade , Animais , Césio/farmacologia , Relação Dose-Resposta à Radiação , Estimulação Elétrica/métodos , Humanos , Técnicas In Vitro , Masculino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/efeitos da radiação , Ratos , Ratos Wistar , Tempo de Reação/fisiologia , Tempo de Reação/efeitos da radiação , Nervo Sural/citologia , Nervo Vago/citologiaRESUMO
Activity-dependent fluctuations in axonal excitability and changes in interspike intervals modify the conduction of trains of action potentials in unmyelinated peripheral nerve fibers. During inflammation of a nerve trunk, long stretches of axons are exposed to inflammatory mediators such as 5-hydroxytryptamine [5-HT]. In the present study, we have tested the effects of m-chlorophenylbiguanide (mCPBG), an agonist at the 5-HT(3) serotonin receptor, on activity- and potential-dependent variations in membrane threshold and conduction velocity of unmyelinated C-fiber axons of isolated rat sural nerve segments. The increase in axonal excitability during application of mCPBG was much stronger at higher frequencies of action potentials and/or during axonal membrane hyperpolarization. The effects on the postspike recovery cycle also depended on the rate of stimulation. At an action potential frequency of 1 Hz or in hyperpolarized axons, mCPBG produced a loss of superexcitability. In contrast, at 0.33 Hz, a small increase in the postspike subexcitability was observed. Similar effects on excitability changes were found when latency instead of threshold was recorded, but only at higher action potential frequencies: at 1.8 Hz, mCPBG increased conduction velocity and reduced postspike supernormality. The latter effect would increase the interspike interval if pairs of action potentials were conducted along several cm in an inflamed nerve trunk. These data indicate that activation of axonal 5-HT(3) receptors not only enhances membrane excitability but also modulates action potential trains in unmyelinated, including nociceptive, nerve fibers at high impulse rates.
Assuntos
Axônios/fisiologia , Fibras Nervosas Amielínicas/fisiologia , Receptores 5-HT3 de Serotonina/fisiologia , Animais , Biguanidas/farmacologia , Eletrofisiologia , Técnicas In Vitro , Potenciais da Membrana/fisiologia , Condução Nervosa/efeitos dos fármacos , Condução Nervosa/fisiologia , Sistema Nervoso Periférico/citologia , Sistema Nervoso Periférico/efeitos dos fármacos , Sistema Nervoso Periférico/fisiologia , Ratos , Ratos Wistar , Serotonina/metabolismoRESUMO
The novel alpha-conotoxin Vc1.1 is a potential analgesic for the treatment of painful neuropathic conditions. In the present study, the effects of Vc1.1 were tested on the nicotine-induced increase in excitability of unmyelinated C-fiber axons in isolated segments of peripheral human nerves. Vc1.1 in concentrations above 0.1 microM antagonized the increase in axonal excitability produced by nicotine; the maximal inhibition was observed with 10 microM. We also demonstrate immunoreactivity for alpha 3 and alpha 5 subunits of neuronal nicotinic receptors on unmyelinated peripheral human axons. Blockade of nicotinic receptors on unmyelinated peripheral nerve fibers may be helpful in painful neuropathies affecting unmyelinated sympathetic and/or sensory axons.
Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Conotoxinas/farmacologia , Fibras Nervosas Amielínicas/efeitos dos fármacos , Receptores Nicotínicos/metabolismo , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Idoso , Idoso de 80 Anos ou mais , Relação Dose-Resposta a Droga , Interações Medicamentosas , Feminino , Humanos , Imuno-Histoquímica/métodos , Masculino , Pessoa de Meia-Idade , Fibras Nervosas Amielínicas/metabolismo , Condução Nervosa/efeitos dos fármacos , Nicotina/farmacologia , Agonistas Nicotínicos , Doenças do Sistema Nervoso Periférico/fisiopatologia , Receptores Nicotínicos/classificaçãoAssuntos
Receptores Purinérgicos P2/metabolismo , Nervo Vago/metabolismo , Potenciais de Ação/efeitos dos fármacos , Trifosfato de Adenosina/farmacologia , Idoso , Sistema Nervoso Autônomo/metabolismo , Cálcio/metabolismo , Estimulação Elétrica , Eletrodos , Eletrofisiologia , Corantes Fluorescentes , Humanos , Masculino , Pessoa de Meia-Idade , Receptores Purinérgicos P2X3RESUMO
Recent evidence suggests that changes in membrane potential influence the proliferation and differentiation of keratinocytes. To further elucidate the role of changes in membrane potential for their biological fate, the electrical behavior of keratinocytes needs to be studied under complex conditions such as multilayered cultures. However, electrophysiological recordings from cells in the various layers of a complex culture would be extremely difficult. Given the high spatial resolution of confocal imaging and the availability of novel voltage-sensitive dyes, we combined these methods in an attempt to develop a viable alternative for recording membrane potentials in more complex tissue systems. As a first step, we used confocal ratiometric imaging of fluorescence resonance energy transfer (FRET)-based voltage-sensitive dyes. We then validated this approach by comparing the optically recorded voltage signals in HaCaT keratinocytes with the electrophysiological signals obtained by whole cell recordings of the same preparation. We demonstrate 1) that optical recordings allow precise multisite measurements of voltage changes evoked by the extracellular signaling molecules ATP and bradykinin and 2) that responsiveness to ATP differs in various layers of cultured keratinocytes.
Assuntos
Trifosfato de Adenosina/farmacologia , Transferência Ressonante de Energia de Fluorescência , Queratinócitos/fisiologia , Queratinócitos/ultraestrutura , Microscopia Confocal , Células Cultivadas , Corantes Fluorescentes , Humanos , Queratinócitos/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Sensibilidade e Especificidade , Fatores de TempoRESUMO
Receptors for ATP in the peripheral nervous system may contribute to the transduction of sensory, including nociceptive, stimuli and are candidates in the pathogenesis of neuropathic pain. In a complex neural tissue, such as the human peripheral nerve trunk, ATP may activate P2X, P2Y, and adenosine receptors present on various cell types. Experiments were performed on segments of isolated human sural nerves. The experimental set-up enabled simultaneous recording of C fiber excitability, intracellular Ca(2+) ([Ca(2+)](i)) and extracellular K(+) activity (aK(e)). The increase in excitability of unmyelinated fibers seen during bath application of both ATP and adenosine was reversed to a reduction in axonal excitability in the presence of 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolol[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385), an antagonist of adenosine A2 receptors. The pharmacological profile of the axonal subexcitability indicates the presence and activation of adenosine A1 receptors. Intracellular Ca(2+) transients were observed during bath application of ATP but not of adenosine and were blocked by 2'-deoxy- N(6)-methyladenosine 3',5'-bisphosphate (MRS 2179), an antagonist at P2Y(1) receptors. K(+)-sensitive microelectrodes were used to search for a possible activation of P2X receptors by ATP. In isolated rat vagus nerve, activation of P2X receptors by alpha,beta-methylene-adenosine 5'-triphosphate (alpha,beta-meATP) and by diadenosine pentaphosphate (Ap5A) resulted in a rapid, transient rise in the extracellular K(+) activity. In contrast, in human nerve, application of P2X receptor agonists did not result in a detectable elevation of aK(e). The data suggest that ATP-induced changes in axonal excitability and of [Ca(2+)](i) result from activation of adenosine A2, A1 and P2Y nucleotide receptors in human nerve; a contribution of P2X receptors was not found with the methods used. It is suggested that antagonists of A2 receptors might suppress enhanced activity in human nociceptive afferent nerve fibers under conditions in which ATP and/or adenosine is released into the trunk of a human peripheral nerve.
Assuntos
Trifosfato de Adenosina/farmacologia , Nervos Periféricos/efeitos dos fármacos , Receptores Purinérgicos P1/metabolismo , Receptores Purinérgicos P2/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Cálcio/metabolismo , Feminino , Humanos , Técnicas In Vitro , Masculino , Pessoa de Meia-Idade , Nervos Periféricos/metabolismo , Agonistas do Receptor Purinérgico P1 , Agonistas do Receptor Purinérgico P2 , Ratos , Ratos WistarRESUMO
Recent studies indicate that effects of ATP on unmyelinated afferent nerve fibres contribute to the transduction of nociceptive and non-nociceptive stimuli. In the present study, effects of ATP were studied on axons and Schwann cells of C fibres in isolated rat vagus nerves. A combination of a computerised threshold tracking technique with photometric and confocal measurements of the free intracellular Ca2+ concentration revealed differences in the effect of ATP and related compounds. Pyridoxal-phosphate-6-azophenyl-2',5'-disulphonic acid (iso-PPADS, an antagonist of ionotropic P2X receptors) completely blocked the excitatory effect of alpha,beta-meATP on unmyelinated axons, whereas the effects of ATP and 2-Cl-ATP were only slightly changed. Moreover, the threshold lowering effects of ATP and 2-Cl-ATP, but not of alpha,beta-meATP, were accompanied by intracellular Ca2+ transients. In confocal imaging experiments, the lectin IB4 was used to identify unmyelinated nerve fibres and their ensheathing Schwann cells. The Schwann cells were identified as the cellular elements underlying ATP-induced Ca2+ transients. In addition, an increase in axonal excitability of C fibres was seen during a rise in [Ca2+]i induced by inhibition of the endoplasmic Ca2 ATPase with cyclopiazonic acid. These data show that an increase of the extracellular ATP concentration in an intact peripheral nerve trunk activates both axons and Schwann cells. It appears that P2 nucleotide receptors on Schwann cells may contribute to the excitatory effect of ATP observed on unmyelinated, including nociceptive, axons.
Assuntos
Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/farmacologia , Axônios/efeitos dos fármacos , Fibras Nervosas/efeitos dos fármacos , Células de Schwann/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Animais , Axônios/fisiologia , Cálcio/metabolismo , ATPases Transportadoras de Cálcio/antagonistas & inibidores , ATPases Transportadoras de Cálcio/metabolismo , Masculino , Fibras Nervosas/fisiologia , Inibidores da Agregação Plaquetária/farmacologia , Fosfato de Piridoxal/análogos & derivados , Fosfato de Piridoxal/farmacologia , Ratos , Ratos Wistar , Células de Schwann/fisiologia , Nervo Vago/efeitos dos fármacos , Nervo Vago/fisiologiaRESUMO
Unmyelinated nociceptive fibres are a key element in the human nociceptive system, however, it is very difficult to investigate such fibres in vivo in more detail. An alternate approach are studies on isolated human nerves. Here we describe that confocal Ca2+ imaging reveals new information about the physiology of human nociceptive C fibres. Confocal images at two emission wavelengths were collected from regions with unmyelinated nerve fibres within segments of biopsied human sural nerves stained with the Ca2+-sensitive fluorescent dyes Calcium Green-1 and Fura Red. Short trains of supramaximal electrical stimuli applied to one end of the nerve as well as bath application of capsaicin resulted in an increase in the free intracellular Ca2+ concentration. Intracellular Ca2+ transients were seen at action potential frequencies above 1 Hz. They were absent in Ca2+-free bathing solution and reduced during bath application of cadmium. This indicates an extracellular source of the activity-dependent rise in [Ca2+]i. Furthermore, Ca2+ transients were also observed during elevation of the extracellular K+ concentration or during short trains of calcium action potentials. Such 'Ca2+ spikes' were elicited by a combination of tetrodotoxin and potassium channel blockers. These data suggest the presence of voltage-dependent Ca2+ channels in the membrane of nociceptive human nerve fibres.